Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
elezanumab | repulsive guidance molecule a | NA | Clinical trial target | TTD , DGIDB | Spinal Cord Injuries[MeSHID:D013119] Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | phase 2 | unknown |
elezanumab | repulsive guidance molecule a | NA | Clinical trial target | TTD , DGIDB | Spinal Cord Injuries[MeSHID:D013119] Multiple Sclerosis[MeSHID:D009103] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
127.3 | phase 2 | antibody |
click here to return to the previous page |